Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accumulated Expenses (2020 - 2025)

BioAtla (BCAB) has 6 years of Accumulated Expenses data on record, last reported at $1.1 million in Q1 2025.

  • For Q1 2025, Accumulated Expenses changed N/A year-over-year to $1.1 million; the TTM value through Mar 2025 reached $1.1 million, changed N/A, while the annual FY2024 figure was $2.7 million, 28.07% down from the prior year.
  • Accumulated Expenses reached $1.1 million in Q1 2025 per BCAB's latest filing, down from $2.7 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $3.8 million in Q4 2023 and bottomed at $833000.0 in Q1 2021.
  • Average Accumulated Expenses over 5 years is $2.5 million, with a median of $2.7 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: rose 29.2% in 2022, then dropped 28.07% in 2024.
  • A 5-year view of Accumulated Expenses shows it stood at $2.7 million in 2021, then increased by 29.2% to $3.5 million in 2022, then increased by 9.82% to $3.8 million in 2023, then decreased by 28.07% to $2.7 million in 2024, then crashed by 58.8% to $1.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $1.1 million in Q1 2025, $2.7 million in Q4 2024, and $3.1 million in Q3 2024.